Emergence of tick-borne encephalitis (TBE) in the Netherlands.


Journal

Ticks and tick-borne diseases
ISSN: 1877-9603
Titre abrégé: Ticks Tick Borne Dis
Pays: Netherlands
ID NLM: 101522599

Informations de publication

Date de publication:
01 2019
Historique:
received: 30 06 2018
revised: 16 10 2018
accepted: 24 10 2018
pubmed: 6 11 2018
medline: 12 2 2019
entrez: 3 11 2018
Statut: ppublish

Résumé

Recently, tick-borne encephalitis virus (TBEV) was detected in the Netherlands for the first time, in ticks collected in 2015 in the National Park Sallandse heuvelrug in response to the detection of anti-TBEV antibodies in roe deer. Hereafter, two human cases of autochthonous TBE have been reported, occurring in 2016. One case was geographically linked to the area of the previously reported ticks, which harbored a genetically divergent TBEV-Eu strain variant (TBEV-NL). So far these are the few reported events that point to endemic transmission of TBEV in the Netherlands and the true prevalence of TBEV and TBE disease in the Netherlands and its impact on the human population remains to be determined. We describe the third human case, identified in 2017, which geographically clusters with the aforementioned case and TBEV-positive ticks. We also describe the identification of another TBEV-NL-positive tick in the Netherlands, collected 2 years after the initial find in that same region (in 2017). These observations support the concept of continued circulation of TBEV-NL and the presence of a possible TBEV hot spot in the Sallandse Heuvelrug region.

Identifiants

pubmed: 30385073
pii: S1877-959X(18)30281-4
doi: 10.1016/j.ttbdis.2018.10.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-179

Informations de copyright

Copyright © 2018 Elsevier GmbH. All rights reserved.

Auteurs

Margriet Dekker (M)

Department of Internal Medicine, Ziekenhuis Groep Twente, Almelo, Hengelo, the Netherlands.

Gozewijn Dirk Laverman (GD)

Department of Internal Medicine, Ziekenhuis Groep Twente, Almelo, Hengelo, the Netherlands.

Ankje de Vries (A)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Johan Reimerink (J)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Felix Geeraedts (F)

Laboratory for Medical Microbiology and Public Health, Hengelo, the Netherlands. Electronic address: f.geeraedts@labmicta.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH